In HF, blood-based biomarkers associated with AD, such as beta-amyloid, tau, glial fibrillary acidic protein (GFAP), and neurofilament-light can foreshadow cognitive decline and correlate to the severity of HF [38,39]. The gene discussed is MAPT; the disease is hydrops fetalis.